OrthoPediatrics (FRA:2X7) Total Receivables: €47.1 Mil (As of Mar. 2026)


FRA:2X7 OrthoPediatrics Corp FRA:2X7
77 GF Score
Price €17.00
GF Value €29.34
! 5 Warning Signs
View Full Analysis

What is OrthoPediatrics Total Receivables?

OrthoPediatrics FRA:2X7 +1.80% 77 Total Receivables is €47.1 Mil as of Mar. 2026. GuruFocus rates FRA:2X7 with a GF Score™ of 77/100 and a GF Value™ of €29.34. The stock has 5 warning signs investors should review.

OrthoPediatrics's Total Receivables for the quarter that ended in Mar. 2026 was €47.1 Mil.

OrthoPediatrics Total Receivables Related Terms

OrthoPediatrics Total Receivables Historical Data

* Premium members only.

The historical data trend for OrthoPediatrics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrthoPediatrics Total Receivables Chart

OrthoPediatrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.88 23.41 31.74 40.45 45.98

OrthoPediatrics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.69 46.64 43.69 45.98 47.08
FRA:2X7
77GF Score
OrthoPediatrics Corp FRA:2X7
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrthoPediatrics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €47.1 Mil mean?
OrthoPediatrics (FRA:2X7) has a Total Receivables of €47.1 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on OrthoPediatrics and its competitors.
Is OrthoPediatrics' Total Receivables too high?
OrthoPediatrics' current Total Receivables is €47.1 Mil. Overall, OrthoPediatrics has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does OrthoPediatrics' Total Receivables compare to PACB and CLPT?
OrthoPediatrics' Total Receivables of €47.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on OrthoPediatrics and its competitors. OrthoPediatrics's current Total Receivables is €47.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrthoPediatrics stock overvalued right now?
OrthoPediatrics (FRA:2X7) has a current Total Receivables of €47.1 Mil. The stock's GF Value™ is €29.34, compared to a current price of €17.00 — trading 42.1% below its estimated fair value. The current Total Receivables is €47.1 Mil. OrthoPediatrics' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For OrthoPediatrics (FRA:2X7), the current Total Receivables is €47.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €17.00 is trading 42.1% below its estimated GF Value™ of €29.34.

Key valuation signals for FRA:2X7:

  • Total Receivables: €47.1 Mil
  • GF Value™: €29.34 vs. price of €17.00 (42.1% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
77GF Score

Get the complete analysis for FRA:2X7

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.00
Price
€29.34
GF Value